The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes
Open accessAbstract
After being absorbed, drugs distribute in the body in part to reach target tissues, in part to be disposed in tissues where they do not exert clinically-relevant effects. Therapeutically-relevant effects are usually terminated by drug metabolism and/or elimination. The role that has been traditionally ascribed to the spleen in these fundamental pharmacokinetic processes was definitely marginal. However, due to its high blood flow and to the characteristics of its microcirculation, this organ would be expected to be significantly exposed to large, new generation drugs that can hardly penetrate in other tissues with tight endothelial barriers. In the present review, we examine the involvement of the spleen in the disposition of monoclonal antibodies, nanoparticles and exosomes and the possible implications for their therapeutic efficacy and toxicity. The data that we will review lead to the conclusion that a new role is emerging for the spleen in the pharmacokinetics of new generation drugs, hence suggesting that this small, neglected organ will certainly deserve stronger attention by pharmacologists in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186
Biological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Routes and mechanisms of extracellular vesicle uptake
Mulcahy, L. A., Pink, R. C., & Carter, D. R. F. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.24641 · Cited by 2,832
FcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
Structure and function of the spleen
Mebius, R. E., & Kraal, G. (2005) · Nature Reviews Immunology · doi:10.1038/nri1669 · Cited by 2,238
Vlassov, A. V., Magdaleno, S., Setterquist, R., & Conrad, R. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.03.017 · Cited by 1,930
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., & Chan, W. C. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2084338 · Cited by 1,926
Rooijen, N. V., & Sanders, A. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90012-4 · Cited by 1,779
Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W., Miller, D., & Zhang, H.-G. (2010) · Molecular Therapy · doi:10.1038/mt.2010.105 · Cited by 1,572
Nanoparticle uptake: The phagocyte problem
Gustafson, H. H., Holt-Casper, D., Grainger, D. W., & Ghandehari, H. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.006 · Cited by 1,411
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,227
Microvascular fluid exchange and the revised Starling principle
Levick, J. R., & Michel, C. C. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq062 · Cited by 1,183
Using exosomes, naturally-equipped nanocarriers, for drug delivery
Batrakova, E. V., & Kim, M. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.030 · Cited by 1,041
Ernsting, M. J., Murakami, M., Roy, A., & Li, S.-D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.013 · Cited by 1,012
Cellular Internalization of Exosomes Occurs Through Phagocytosis
Feng, D., Zhao, W.-L., Ye, Y.-Y., Bai, X.-C., Liu, R.-Q., Chang, L.-F., Zhou, Q., & Sui, S.-F. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01041.x · Cited by 981
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
Wang, W., Wang, E., & Balthasar, J. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.170 · Cited by 978
T Cell-Independent Antigens Type 2
Mond, J. J. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.655 · Cited by 824
Glossary of terms used in toxicology, 2nd edition (IUPAC Recommendations 2007)
Duffus, J. H., Nordberg, M., & Templeton, D. M. (2007) · Pure and Applied Chemistry · doi:10.1351/pac200779071153 · Cited by 787
Exosomes: Vehicles of Intercellular Signaling, Biomarkers, and Vectors of Cell Therapy
Kourembanas, S. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071641 · Cited by 761
Parameters influencing the stealthiness of colloidal drug delivery systems
Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740
Normal structure, function, and histology of the spleen
Cesta, M. F. (2006) · Toxicologic Pathology · doi:10.1080/01926230600867743 · Cited by 731
Takahashi, Y., Nishikawa, M., Shinotsuka, H., Matsui, Y., Ohara, S., Imai, T., & Takakura, Y. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.03.013 · Cited by 728
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
Abu Lila, A. S., Kiwada, H., & Ishida, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.026 · Cited by 721 · cited 3×
“Thereafter, ABC was observed with other PEGylated liposome preparations [117,118] and, also, with other non-liposomal PEG-containing-nanoparticles, such as microemulsions, polymeric micelles, polymeric nanoparticles and PEGylated proteins [117].”
BackgroundJunghans, R. P., & Anderson, C. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5512 · Cited by 684
Much More than M1 and M2 Macrophages, There are also CD169+ and TCR+ Macrophages
Chávez-Galán, L., Olleros, M. L., Vesin, D., & Garcia, I. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00263 · Cited by 653
Dams, E. T. M., Laverman, P., Oyen, W. J. G., Storm, G., Scherphof, G. L., van der Meer, J. W. M., Corstens, F. H. M., & Boerman, O. C. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35391-1 · Cited by 607
Imai, T., Takahashi, Y., Nishikawa, M., Kato, K., Morishita, M., Yamashita, T., Matsumoto, A., Charoenviriyakul, C., & Takakura, Y. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.26238 · Cited by 579
Physiologically Based Pharmacokinetic Modeling: Principles and Applications
Gerlowski, L. E., & Jain, R. K. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600721003 · Cited by 576
The follicular versus marginal zone B lymphocyte cell fate decision
Pillai, S., & Cariappa, A. (2009) · Nature Reviews Immunology · doi:10.1038/nri2656 · Cited by 570
Sarin, H. (2010) · Journal of Angiogenesis Research · doi:10.1186/2040-2384-2-14 · Cited by 562
Ishida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 557
Sheddable Coatings for Long-Circulating Nanoparticles
Romberg, B., Hennink, W. E., & Storm, G. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9348-7 · Cited by 555
Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective
Moghimi, S. M., Hunter, A. C., & Andresen, T. L. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134623 · Cited by 545
Recent advances in stealth coating of nanoparticle drug delivery systems
Amoozgar, Z., & Yeo, Y. (2012) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1157 · Cited by 528
Therapeutic Applications of Extracellular Vesicles: Clinical Promise and Open Questions
György, B., Hung, M. E., Breakefield, X. O., & Leonard, J. N. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124630 · Cited by 515
Rao, L., Bu, L., Xu, J., Cai, B., Yu, G., Yu, X., He, Z., Huang, Q., Li, A., Guo, S., et al. (2015) · Small · doi:10.1002/smll.201502388 · Cited by 513
Understanding and Overcoming Major Barriers in Cancer Nanomedicine
Nie, S. (2010) · Nanomedicine · doi:10.2217/nnm.10.23 · Cited by 498
Which polymers can make nanoparticulate drug carriers long-circulating?
Torchilin, V. P., & Trubetskoy, V. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00022-y · Cited by 480
Abnormally short serum half‐lives of IgG in β2‐microglobulin‐deficient mice
Ghetie, V., Hubbard, J. G., Kim, J., Tsen, M., Lee, Y., & Ward, E. S. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260327 · Cited by 469
Monoclonal antibody therapeutics: history and future
Buss, N. A., Henderson, S. J., McFarlane, M., Shenton, J. M., & de Haan, L. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.08.001 · Cited by 434
Shah, D. K., & Betts, A. M. (2012) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-011-9232-2 · Cited by 422
Peracchia, M. T., Fattal, E., Desmaële, D., Besnard, M., Noël, J. P., Gomis, J. M., Appel, M., d’Angelo, J., & Couvreur, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00063-2 · Cited by 400
CD169 mediates the capture of exosomes in spleen and lymph node
Saunderson, S. C., Dunn, A. C., Crocker, P. R., & McLellan, A. D. (2014) · Blood · doi:10.1182/blood-2013-03-489732 · Cited by 395
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Ishida, T., Wang, X., Shimizu, T., Nawata, K., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.015 · Cited by 382
Ishida, T., Harada, M., Wang, X. Y., Ichihara, M., Irimura, K., & Kiwada, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.003 · Cited by 365
Patel, V. L., Mahévas, M., Lee, S. Y., Stasi, R., Cunningham-Rundles, S., Godeau, B., Kanter, J., Neufeld, E., Taube, T., Ramenghi, U., et al. (2012) · Blood · doi:10.1182/blood-2011-11-393975 · Cited by 348
Adhesion and signaling by B cell‐derived exosomes: the role of integrins
Clayton, A., Turkes, A., Dewitt, S., Steadman, R., Mason, M. D., & Hallett, M. B. (2004) · The FASEB Journal · doi:10.1096/fj.03-1094fje · Cited by 339
Garg, A., & Balthasar, J. P. (2007) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-007-9065-1 · Cited by 327
In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft
Nagengast, W. B., de Vries, E. G., Hospers, G. A., Mulder, N. H., de Jong, J. R., Hollema, H., Brouwers, A. H., van Dongen, G. A., Perk, L. R., & Lub-de Hooge, M. N. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.041301 · Cited by 313
Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice.
Covell, D. G., Barbet, J., Holton, O. D., BLACK, C. D. V., Parker, R. J., & Weinstein, J. N. (1986) · PubMed · Cited by 311
Biodistribution Mechanisms of Therapeutic Monoclonal Antibodies in Health and Disease
Tabrizi, M., Bornstein, G. G., & Suria, H. (2010) · The AAPS Journal · doi:10.1208/s12248-009-9157-5 · Cited by 305
Laverman, P., Carstens, M. G., Boerman, O. C., Th. M. Dams, E., Oyen, W. J. G., van Rooijen, N., Corstens, F. H. M., & Storm, G. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29419-2 · Cited by 298
Barrès, C., Blanc, L., Bette-Bobillo, P., André, S., Mamoun, R., Gabius, H.-J., & Vidal, M. (2010) · Blood · doi:10.1182/blood-2009-07-231449 · Cited by 297
Serum opsonins and liposomes: their interaction and opsonophagocytosis.
Patel, H. M. (1992) · PubMed · Cited by 297
Morishita, M., Takahashi, Y., Nishikawa, M., Sano, K., Kato, K., Yamashita, T., Imai, T., Saji, H., & Takakura, Y. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24251 · Cited by 285
Moghimi, S. M., Porter, C. J. H., Muir, I. S., Illum, L., & Davis, S. S. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91869-e · Cited by 282
Normal Organ Weights in Men: Part II—The Brain, Lungs, Liver, Spleen, and Kidneys
Molina, D. K., & DiMaio, V. J. M. (2012) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0b013e31823d29ad · Cited by 273
Ishida, T., Ichihara, M., Wang, X., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.001 · Cited by 270
Neonatal FcR Expression in Bone Marrow-Derived Cells Functions to Protect Serum IgG from Catabolism
Akilesh, S., Christianson, G. J., Roopenian, D. C., & Shaw, A. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4580 · Cited by 269
Godeau, B., Porcher, R., Fain, O., Lefrère, F., Fenaux, P., Cheze, S., Vekhoff, A., Chauveheid, M.-P., Stirnemann, J., Galicier, L., et al. (2008) · Blood · doi:10.1182/blood-2008-01-131029 · Cited by 244
Controlling liposome blood clearance by surface-grafted polymers
Woodle, M. C. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00136-1 · Cited by 242
Noninvasive imaging of radiolabeled exosome-mimetic nanovesicle using 99mTc-HMPAO
Hwang, D. W., Choi, H., Jang, S. C., Yoo, M. Y., Park, J. Y., Choi, N. E., Oh, H. J., Ha, S., Lee, Y.-S., Jeong, J. M., et al. (2015) · Scientific Reports · doi:10.1038/srep15636 · Cited by 233
Human spleen microanatomy: why mice do not suffice
Steiniger, B. S. (2015) · Immunology · doi:10.1111/imm.12469 · Cited by 231
CD20 as a Target for Therapeutic Type I and II Monoclonal Antibodies
Beers, S. A., Chan, C. H. T., French, R. R., Cragg, M. S., & Glennie, M. J. (2010) · Seminars in Hematology · doi:10.1053/j.seminhematol.2010.01.001 · Cited by 209
B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
Mahévas, M., Patin, P., Huetz, F., Descatoire, M., Cagnard, N., Bole-Feysot, C., Le Gallou, S., Khellaf, M., Fain, O., Boutboul, D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65689 · Cited by 202
Dutta, T., & Jain, N. K. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.12.007 · Cited by 200
Deng, R., Bumbaca, D., Pastuskovas, C. V., Boswell, C. A., West, D., Cowan, K. J., Chiu, H., McBride, J., Johnson, C., Xin, Y., et al. (2016) · mAbs · doi:10.1080/19420862.2015.1136043 · Cited by 199
Poon, K. A., Flagella, K., Beyer, J., Tibbitts, J., Kaur, S., Saad, O., Yi, J.-H., Girish, S., Dybdal, N., & Reynolds, T. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.09.003 · Cited by 198
Moghimi, S. M., Hedeman, H., Muir, I. S., Illum, L., & Davis, S. S. (1993) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(93)90105-h · Cited by 176
Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule.
van den Berg, T. K., Brevé, J. J., Damoiseaux, J. G., Döpp, E. A., Kelm, S., Crocker, P. R., Dijkstra, C. D., & Kraal, G. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.3.647 · Cited by 170
Huang, H., Benoist, C., & Mathis, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001074107 · Cited by 159
Koide, H., Asai, T., Hatanaka, K., Akai, S., Ishii, T., Kenjo, E., Ishida, T., Kiwada, H., Tsukada, H., & Oku, N. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.022 · Cited by 157
Revision of the Starling principle: new views of tissue fluid balance
Levick, J. R. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.066118 · Cited by 152
Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles
Fattal, E., Youssef, M. T., Couvreur, P., & Andremont, A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1540 · Cited by 149
Accelerated Clearance of Polyethylene Glycol-Modified Proteins by Anti-Polyethylene Glycol IgM
Cheng, T., Wu, P.-Y., Wu, M., Chern, J., & Roffler, S. R. (1999) · Bioconjugate Chemistry · doi:10.1021/bc980143z · Cited by 147
Kao, Y. J., & Juliano, R. L. (1981) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(81)90259-2 · Cited by 146
Moghimi, S. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00043-7 · Cited by 142
Ferl, G. Z., Wu, A. M., & DiStefano, J. J. (2005) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-7410-3 · Cited by 142
Effective B Cell Depletion with Rituximab in the Treatment of Autoimmune Diseases
Kneitz, C. (2002) · Immunobiology · doi:10.1078/0171-2985-00200 · Cited by 140
The Perifollicular and Marginal Zones of the Human Splenic White Pulp
Steiniger, B. S., Barth, P. J., & Hellinger, A. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61722-1 · Cited by 137
Chiannilkulchai, N., Ammoury, N., Caillou, B., Devissaguet, J. P., & Couvreur, P. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf02897257 · Cited by 130
Suzuki, T., Ichihara, M., Hyodo, K., Yamamoto, E., Ishida, T., Kiwada, H., Ishihara, H., & Kikuchi, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.049 · Cited by 127
The future of antibodies as cancer drugs
Reichert, J. M., & Dhimolea, E. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.04.006 · Cited by 125
Spleen: A new role for an old player?
Tarantino, G. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i33.3776 · Cited by 123
Immunologic effects of rituximab on the human spleen in immune thrombocytopenia
Audia, S., Samson, M., Guy, J., Janikashvili, N., Fraszczak, J., Trad, M., Ciudad, M., Seguin, V. L., Berthier, S., Petrella, T., et al. (2011) · Blood · doi:10.1182/blood-2011-03-344051 · Cited by 119
Biewenga, J., van der Ende, M. B., Krist, L. F. G., Borst, A., Ghufron, M., & van Rooijen, N. (1995) · Cell and Tissue Research · doi:10.1007/bf00304524 · Cited by 111
Kurihara, H., Hamada, A., Yoshida, M., Shimma, S., Hashimoto, J., Yonemori, K., Tani, H., Miyakita, Y., Kanayama, Y., Wada, Y., et al. (2015) · EJNMMI Research · doi:10.1186/s13550-015-0082-6 · Cited by 111
Li, Y., Liu, R., Shi, Y., Zhang, Z., & Zhang, X. (2015) · Theranostics · doi:10.7150/thno.11234 · Cited by 109
Han, T. H., & Zhao, B. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058586 · Cited by 101
Shimizu, T., Ishida, T., & Kiwada, H. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.08.274 · Cited by 94
Baik, J., & Rosania, G. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047494 · Cited by 91
Targeting FcRn for the modulation of antibody dynamics
Ward, E. S., Devanaboyina, S. C., & Ober, R. J. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.02.007 · Cited by 90
Fernández‐Urrusuno, R., Fattal, E., Rodrigues, J. M., F�ger, J., Bédossa, P., & Couvreur, P. (1996) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199607)31:3<401::aid-jbm15>3.0.co;2-l · Cited by 90
Yip, V., Palma, E., Tesar, D. B., Mundo, E. E., Bumbaca, D., Torres, E. K., Reyes, N. A., Shen, B., Fielder, P. J., Prabhu, S., et al. (2014) · mAbs · doi:10.4161/mabs.28254 · Cited by 89
Rituximab: A promising therapy in systemic lupus erythematosus
Thatayatikom, A., & White, A. J. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.05.006 · Cited by 89
Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients
Toki, D., Ishida, H., Horita, S., Setoguchi, K., Yamaguchi, Y., & Tanabe, K. (2008) · Transplant International · doi:10.1111/j.1432-2277.2008.00821.x · Cited by 87
Siest, G., Jeannesson, É., Marteau, J., Samara, A., Bastien, B., Pfister, M., & Visvikis‐Siest, S. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017228 · Cited by 86
Future of Monoclonal Antibodies in the Treatment of Hematologic Malignancies
Reff, M. E., Hariharan, K., & Braslawsky, G. R. (2002) · Cancer Control · doi:10.1177/107327480200900207 · Cited by 83
Schmidt, E. E., MacDonald, I. C., & Groom, A. C. (1993) · PubMed · Cited by 82
Antileishmanial activity of nano-amphotericin B deoxycholate
Manandhar, K. D., Yadav, T. P., Prajapati, V. K., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn189 · Cited by 78
Youssef, M. T., Fattal, E., Alonso, M. J., Roblot-Treupel, L., Sauzieres, J., Tancrède, C., Omnès, A., Couvreur, P., & Andremont, A. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.8.1204 · Cited by 74
Use of lllIndium‐labelled Platelets to Measure Spleen Function
Peters, A. M., Klonizakis, I., Lavender, J. P., et al. (1980) · British Journal of Haematology · doi:10.1111/j.1365-2141.1980.tb06016.x · Cited by 70
Cheng, T., Chen, B., Chern, J., Wu, M., & Roffler, S. R. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990147j · Cited by 67
Malviya, G., Anzola, L. K., Podestà, E., Laganà, B., Mastro, C. D., Dierckx, R., Scopinaro, F., & Signore, A. (2011) · Molecular Imaging and Biology · doi:10.1007/s11307-011-0527-x · Cited by 67
Mahévas, M., Michel, M., Vingert, B., Moroch, J., Boutboul, D., Audia, S., Cagnard, N., Ripa, J., Menard, C., Tarte, K., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.05.006 · Cited by 66
Deng, Y., Yang, P., Ma, Zhao, She, Wang, Li, X., & Wang (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s41701 · Cited by 65
Kumar, G., Sharma, S., Shafiq, N., Pandhi, P., Khuller, G. K., & Malhotra, S. (2010) · Drug Delivery · doi:10.3109/10717544.2010.509367 · Cited by 63
Ahmad, Z., Pandey, R., Sharma, S., & Khuller, G. K. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.10.017 · Cited by 63
Boswell, C. A., Bumbaca, D., Fielder, P. J., & Khawli, L. A. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9374-1 · Cited by 62
Drug transporter expression in human macrophages
Moreau, A., Vée, M. L., Jouan, E., Parmentier, Y., & Fardel, O. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00913.x · Cited by 61
In vivo Distribution of Inorganic Nanoparticles in Preclinical Models
Varna, M., Ratajczak, P., Ferreira, I., Lebœuf, C., Bousquet, G., & Janin, A. (2012) · Journal of Biomaterials and Nanobiotechnology · doi:10.4236/jbnb.2012.322033 · Cited by 61
Ma, Y., Yang, Q., Wang, L., Zhou, X., Zhao, Y., & Deng, Y. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.11.014 · Cited by 61
Semaeva, E., Tenstad, O., Skavland, J., Enger, M., Iversen, P. O., Gjertsen, B. T., & Wiig, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902049 · Cited by 59
Splenic Trapping of Nanoparticles: Complementary Approaches for In Situ Studies
Demoy, M., Gibaud, S., Andreux, J. P., Weingarten, C., Gouritin, B., & Couvreur, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012095431931 · Cited by 58
Ravi, P. R., Vats, R., Balija, J., Adapa, S. P. N., & Aditya, N. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.03.099 · Cited by 58
The Open Microcirculation in Human Spleens
Steiniger, B. S., Bette, M., & Schwarzbach, H. (2011) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155411408315 · Cited by 57
Imbuluzqueta, E., Gamazo, C., Lana, H., Campanero, M. Á., Salas, D., Gil, A. G., Elizondo, E., Ventosa, N., Veciana, J., & Blanco‐Prieto, M. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00378-13 · Cited by 56
van Scheltinga, A. G. T. T., Hooge, M. N. L., Abiraj, K., Schröder, C. P., Pot, L., Bossenmaier, B., Thomas, M., Hölzlwimmer, G., Friess, T., Kosterink, J. G. W., et al. (2014) · mAbs · doi:10.4161/mabs.29097 · Cited by 55
Papp, K., Végh, P., Prechl, J., Kerekes, K., Kovács, J., Csikós, G., Bajtay, Z., & Erdei, A. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2007.11.021 · Cited by 53
Leandro, M. J., & de la Torre, I. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03978.x · Cited by 52
Immunohistology of the human spleen: an inventory of the localization of lymphocyte subpopulations
van Krieken, J. H., & Velde, J. T. (1986) · Histopathology · doi:10.1111/j.1365-2559.1986.tb02482.x · Cited by 47
Ford, J., Boffito, M., Wildfire, A., Hill, A. M., Back, D. J., Khoo, S., Nelson, M. R., Moyle, G. J., Gazzard, B., & Pozniak, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2388-2393.2004 · Cited by 45
Rajendran, J. G., Fisher, D. R., Gopal, A. K., et al. (2004) · PubMed · Cited by 42
Nagao, A., Lila, A. S. A., Ishida, T., & Kiwada, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.11.015 · Cited by 39
In vitro evaluation of nanoparticles spleen capture
Demoy, M., Andreux, J. P., Weingarten, C., Gouritin, B., Guilloux, V., & Couvreur, P. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00068-5 · Cited by 35
Lila, A. S. A., Ichihara, M., Shimizu, T., Ishida, T., & Kiwada, H. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00562 · Cited by 31
Rituximab-Induced Changes in Hematolymphoid Tissues Found at Autopsy
Cioc, A. M., Vanderwerf, S. M., Peterson, B. A., et al. (2008) · American Journal of Clinical Pathology · doi:10.1309/uxle9rhl968ter7b · Cited by 31
Hodges, V. M., Molloy, G. Y., & Wickramasinghe (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01816.x · Cited by 28
Suppression in mice of immunosurveillance against PEGylated liposomes by encapsulated doxorubicin
Yahuafai, J., Asai, T., Nakamura, G., Fukuta, T., Siripong, P., Hyodo, K., Ishihara, H., Kikuchi, H., & Oku, N. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.010 · Cited by 23
6‐mercaptopurine transport in human lymphocytes: Correlation with drug‐induced cytotoxicity
Conklin, L. S., Cuffari, C., OKAZAKI, T., Miao, Y., Saatian, B., Chen, T., Tse, M. C., Brant, S. R., & Li, X. (2011) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2011.00556.x · Cited by 13
Biodistribution of 212Pb conjugated trastuzumab in mice
Schneider, N. R., Lobaugh, M., Tan, Z., Sandwall, P. A., Chen, P., Glover, S. E., Cui, L., Murry, M. M., Dong, Z., Torgue, J. J.-C., et al. (2012) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-012-2243-7 · Cited by 13
Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy
Martinez-Skinner, A., Araínga, M., Puligujja, P., Palandri, D. L., Baldridge, H. M., Edagwa, B., McMillan, J., Mosley, R. L., & Gendelman, H. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145966 · Cited by 13
Hillaireau, H. (2016) · Springer eBooks · doi:10.1007/978-3-319-41421-8_10 · Cited by 9
Cited by
Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery
Antimisiaris, S. G., Mourtas, S., & Marazioti, A. (2018) · doi:10.20944/preprints201810.0507.v1 · Cited by 605
Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery
Antimisiaris, S. G., Mourtas, S., & Marazioti, A. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040218 · Cited by 603
Li, X., Corbett, A. L., Taatizadeh, E., Tasnim, N., Little, J. P., Garnis, C., Daugaard, M., Guns, E., Hoorfar, M., & Li, I. T. S. (2019) · APL Bioengineering · doi:10.1063/1.5087122 · Cited by 564
CAR T-cell therapy in autoimmune diseases
Schett, G., Mackensen, A., & Mougiakakos, D. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01126-1 · Cited by 430
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies
Soetaert, F., Korangath, P., Serantes, D., Fiering, S., & Ivkov, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.025 · Cited by 406
Metadata
- Authors
- Cataldi, M., Vigliotti, C., Mosca, T., Cammarota, M., & Capone, D.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-06-10
- Volume
- 18
- Issue
- 6
- Pages
- 1249
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2622879993
- Cited by
- 267
- References
- 137
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.